CN103536612A - 硝呋太尔-制霉素阴道膨胀栓及其制备方法和检测方法 - Google Patents
硝呋太尔-制霉素阴道膨胀栓及其制备方法和检测方法 Download PDFInfo
- Publication number
- CN103536612A CN103536612A CN201310473186.8A CN201310473186A CN103536612A CN 103536612 A CN103536612 A CN 103536612A CN 201310473186 A CN201310473186 A CN 201310473186A CN 103536612 A CN103536612 A CN 103536612A
- Authority
- CN
- China
- Prior art keywords
- nifuratel
- nysfungin
- expansible plug
- weight
- vagina expansible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000829 suppository Substances 0.000 title claims abstract description 48
- 238000001514 detection method Methods 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 210000001215 vagina Anatomy 0.000 claims abstract description 97
- SRQKTCXJCCHINN-NYYWCZLTSA-N nifuratel Chemical compound O=C1OC(CSC)CN1\N=C\C1=CC=C([N+]([O-])=O)O1 SRQKTCXJCCHINN-NYYWCZLTSA-N 0.000 claims abstract description 37
- 229960002136 nifuratel Drugs 0.000 claims abstract description 37
- 239000003814 drug Substances 0.000 claims abstract description 24
- 238000010521 absorption reaction Methods 0.000 claims abstract description 11
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 11
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 11
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 claims abstract description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- -1 nysfungin Chemical compound 0.000 claims abstract description 10
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims abstract description 8
- 229920000053 polysorbate 80 Polymers 0.000 claims abstract description 8
- 229940093625 propylene glycol monostearate Drugs 0.000 claims abstract description 8
- 239000000758 substrate Substances 0.000 claims description 83
- 235000010603 pastilles Nutrition 0.000 claims description 60
- 239000000203 mixture Substances 0.000 claims description 51
- 229920000742 Cotton Polymers 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000003556 assay Methods 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 125000005456 glyceride group Chemical group 0.000 claims description 14
- 238000002844 melting Methods 0.000 claims description 14
- 230000008018 melting Effects 0.000 claims description 14
- 239000003921 oil Substances 0.000 claims description 13
- 235000019198 oils Nutrition 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000000155 melt Substances 0.000 claims description 10
- 230000008859 change Effects 0.000 claims description 9
- 239000008119 colloidal silica Substances 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 9
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 9
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 9
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 9
- 229960003943 hypromellose Drugs 0.000 claims description 9
- 238000005096 rolling process Methods 0.000 claims description 9
- 229920006395 saturated elastomer Polymers 0.000 claims description 9
- 235000019197 fats Nutrition 0.000 claims description 8
- 235000021357 Behenic acid Nutrition 0.000 claims description 6
- UKMSUNONTOPOIO-UHFFFAOYSA-N Behenic acid Natural products CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 229940116226 behenic acid Drugs 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000004519 grease Substances 0.000 claims description 6
- 238000007493 shaping process Methods 0.000 claims description 6
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 241000549173 Celastrus scandens Species 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 239000007766 cera flava Substances 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 4
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 claims description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims description 4
- 244000060011 Cocos nucifera Species 0.000 claims description 3
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 claims description 3
- 229960000502 poloxamer Drugs 0.000 claims description 3
- 229920001983 poloxamer Polymers 0.000 claims description 3
- 229960001947 tripalmitin Drugs 0.000 claims description 3
- 238000004506 ultrasonic cleaning Methods 0.000 claims description 3
- 235000003276 Apios tuberosa Nutrition 0.000 claims description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 2
- 235000010744 Arachis villosulicarpa Nutrition 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 239000001828 Gelatine Substances 0.000 claims description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- 239000004203 carnauba wax Substances 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 235000019868 cocoa butter Nutrition 0.000 claims description 2
- 229940110456 cocoa butter Drugs 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 238000004508 fractional distillation Methods 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 2
- 239000000346 nonvolatile oil Substances 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 claims description 2
- 239000012177 spermaceti Substances 0.000 claims description 2
- 229940084106 spermaceti Drugs 0.000 claims description 2
- 239000001993 wax Substances 0.000 claims description 2
- 244000133018 Panax trifolius Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 238000005516 engineering process Methods 0.000 abstract description 13
- 229940079593 drug Drugs 0.000 abstract description 8
- 230000009471 action Effects 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 239000011159 matrix material Substances 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000002035 prolonged effect Effects 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 2
- 208000003322 Coinfection Diseases 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical group OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- 229940069328 povidone Drugs 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 27
- 239000002511 suppository base Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 10
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 6
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 230000007774 longterm Effects 0.000 description 5
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 3
- 206010042566 Superinfection Diseases 0.000 description 3
- 206010046914 Vaginal infection Diseases 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 241001478240 Coccus Species 0.000 description 2
- 241000405070 Percophidae Species 0.000 description 2
- 208000008350 Pruritus Vulvae Diseases 0.000 description 2
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000007790 scraping Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229940044977 vaginal tablet Drugs 0.000 description 2
- 239000000003 vaginal tablet Substances 0.000 description 2
- 244000066764 Ailanthus triphysa Species 0.000 description 1
- 208000007415 Anhedonia Diseases 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002642 Polysorbate 65 Polymers 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 1
- 239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940099511 polysorbate 65 Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 229940120293 vaginal suppository Drugs 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
实施例 | 膨胀前平均直径(mm) | 膨胀后平均直径(mm) | 膨胀值(倍) | 结果 |
实施例1 | 12.33 | 22.48 | 1.82 | 合格 |
实施例2 | 11.91 | 21.36 | 1.79 | 合格 |
实施例3 | 12.05 | 22.54 | 1.87 | 合格 |
实施例4 | 12.17 | 22.66 | 1.86 | 合格 |
实施例5 | 12.09 | 21.47 | 1.77 | 合格 |
实施例6 | 11.98 | 19.12 | 1.60 | 合格 |
实施例7 | 12.24 | 20.67 | 1.69 | 合格 |
实施例8 | 12.13 | 21.93 | 1.81 | 合格 |
组别 | 病例数 | 症愈 | 显效 | 有效 | 无效 | 有效率(%) |
治疗组 | 50 | 40 | 3 | 6 | 1 | 98.0 |
对照组 | 34 | 20 | 5 | 2 | 7 | 79.4 |
组别 | 病例数 | 症愈 | 显效 | 有效 | 无效 | 有效率(%) |
治疗组 | 31 | 25 | 3 | 2 | 1 | 96.8 |
对照组 | 19 | 11 | 1 | 3 | 4 | 78.9 |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310473186.8A CN103536612B (zh) | 2013-10-11 | 2013-10-11 | 硝呋太尔-制霉素阴道膨胀栓及其制备方法和检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310473186.8A CN103536612B (zh) | 2013-10-11 | 2013-10-11 | 硝呋太尔-制霉素阴道膨胀栓及其制备方法和检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103536612A true CN103536612A (zh) | 2014-01-29 |
CN103536612B CN103536612B (zh) | 2016-03-30 |
Family
ID=49960726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310473186.8A Active CN103536612B (zh) | 2013-10-11 | 2013-10-11 | 硝呋太尔-制霉素阴道膨胀栓及其制备方法和检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103536612B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104983671A (zh) * | 2015-06-30 | 2015-10-21 | 哈尔滨欧替药业有限公司 | 重组人粒细胞巨噬细胞刺激因子阴道膨胀栓及其制备方法和检测方法 |
CN111557897A (zh) * | 2020-07-07 | 2020-08-21 | 温州海鹤药业有限公司 | 一种含有硝呋太尔的药物组合物及其制备方法 |
CN113828243A (zh) * | 2021-09-14 | 2021-12-24 | 南京南大药业有限责任公司 | 一种硝呋太尔制霉菌素栓制造方法及设备 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103181889A (zh) * | 2012-11-29 | 2013-07-03 | 哈尔滨欧替药业有限公司 | 膨胀阴道栓剂 |
CN103301098A (zh) * | 2013-06-21 | 2013-09-18 | 哈尔滨欧替药业有限公司 | 复方氯己定盐阴道膨胀栓及其制备方法和检测方法 |
-
2013
- 2013-10-11 CN CN201310473186.8A patent/CN103536612B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103181889A (zh) * | 2012-11-29 | 2013-07-03 | 哈尔滨欧替药业有限公司 | 膨胀阴道栓剂 |
CN103301098A (zh) * | 2013-06-21 | 2013-09-18 | 哈尔滨欧替药业有限公司 | 复方氯己定盐阴道膨胀栓及其制备方法和检测方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104983671A (zh) * | 2015-06-30 | 2015-10-21 | 哈尔滨欧替药业有限公司 | 重组人粒细胞巨噬细胞刺激因子阴道膨胀栓及其制备方法和检测方法 |
CN104983671B (zh) * | 2015-06-30 | 2018-11-02 | 哈尔滨欧替药业有限公司 | 重组人粒细胞巨噬细胞刺激因子阴道膨胀栓及其制备方法和检测方法 |
CN111557897A (zh) * | 2020-07-07 | 2020-08-21 | 温州海鹤药业有限公司 | 一种含有硝呋太尔的药物组合物及其制备方法 |
CN113828243A (zh) * | 2021-09-14 | 2021-12-24 | 南京南大药业有限责任公司 | 一种硝呋太尔制霉菌素栓制造方法及设备 |
CN113828243B (zh) * | 2021-09-14 | 2022-06-28 | 南京南大药业有限责任公司 | 一种硝呋太尔制霉菌素栓制造方法及设备 |
Also Published As
Publication number | Publication date |
---|---|
CN103536612B (zh) | 2016-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103301098B (zh) | 复方氯己定盐阴道膨胀栓及其制备方法和检测方法 | |
CN103520090B (zh) | 替硝唑阴道膨胀栓及其制备方法和检测方法 | |
CN103720640B (zh) | 聚维酮碘阴道膨胀栓及其制备方法和检测方法 | |
CN103784390B (zh) | 塞克硝唑阴道膨胀栓及其制备方法和检测方法 | |
CN103751098B (zh) | 重组人干扰素α2а阴道膨胀栓及其制备方法和检测方法 | |
CN103751094B (zh) | 奥硝唑阴道膨胀栓及其制备方法和检测方法 | |
CN103520604B (zh) | 百草妇炎清阴道膨胀栓及其制备方法和检测方法 | |
CN103536612B (zh) | 硝呋太尔-制霉素阴道膨胀栓及其制备方法和检测方法 | |
CN103536592B (zh) | 甲硝唑呋喃唑酮阴道膨胀栓及其制备方法和检测方法 | |
CN103520380B (zh) | 裸花紫珠阴道膨胀栓及其制备方法和检测方法 | |
CN103520086B (zh) | 硝酸咪康唑阴道膨胀栓及其制备方法和检测方法 | |
CN103893107A (zh) | 硝酸舍他康唑阴道膨胀栓及其制备方法和检测方法 | |
CN103520089B (zh) | 甲硝唑阴道膨胀栓及其制备方法和检测方法 | |
CN103494767B (zh) | 雌三醇阴道膨胀栓及其制备方法和检测方法 | |
CN103768005B (zh) | 酮康唑阴道膨胀栓及其制备方法和检测方法 | |
CN103751097B (zh) | 氧氟沙星阴道膨胀栓及其制备方法和检测方法 | |
CN103520088B (zh) | 制霉素阴道膨胀栓及其制备方法和检测方法 | |
CN103735491A (zh) | 克林霉素磷酸酯阴道膨胀栓及其制备方法和检测方法 | |
CN103494896B (zh) | 蛇黄阴道膨胀栓及其制备方法和检测方法 | |
CN103735492A (zh) | 黄体酮阴道膨胀栓及其制备方法和检测方法 | |
CN103520338A (zh) | 治糜康阴道膨胀栓及其制备方法和检测方法 | |
CN103520635B (zh) | 复方莪术油阴道膨胀栓及其制备方法和检测方法 | |
CN103720638A (zh) | 硝酸芬替康唑阴道膨胀栓及其制备方法和检测方法 | |
CN103768006B (zh) | 特康唑阴道膨胀栓及其制备方法和检测方法 | |
CN103520603A (zh) | 妇炎灵阴道膨胀栓及其制备方法和检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211119 Address after: 150040 office building 7, Bohai Third Road, haping road concentration area, Harbin Economic Development Zone, Harbin, Heilongjiang Province Patentee after: Harbin Tianmei Pharmaceutical Co.,Ltd. Address before: 150069, No. three, No. 7, Bohai, Harbin, Heilongjiang, China Patentee before: HARBIN OT PHARMACEUTICALS Co.,Ltd. Patentee before: Qiu Mingshi |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Nitrofuretyl nystatin vaginal dilation suppository and its preparation and detection method Effective date of registration: 20230704 Granted publication date: 20160330 Pledgee: Harbin Kechuang Financing Guarantee Co.,Ltd. Pledgor: Harbin Tianmei Pharmaceutical Co.,Ltd. Registration number: Y2023230000060 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20160330 Pledgee: Harbin Kechuang Financing Guarantee Co.,Ltd. Pledgor: Harbin Tianmei Pharmaceutical Co.,Ltd. Registration number: Y2023230000060 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Nifurol Nystatin Vaginal Dilation Suppository and Its Preparation and Detection Methods Granted publication date: 20160330 Pledgee: Harbin Kechuang Financing Guarantee Co.,Ltd. Pledgor: Harbin Tianmei Pharmaceutical Co.,Ltd. Registration number: Y2024230000040 |